CA1340519C - Nucleosides antiviraux - Google Patents

Nucleosides antiviraux

Info

Publication number
CA1340519C
CA1340519C CA000616284A CA616284A CA1340519C CA 1340519 C CA1340519 C CA 1340519C CA 000616284 A CA000616284 A CA 000616284A CA 616284 A CA616284 A CA 616284A CA 1340519 C CA1340519 C CA 1340519C
Authority
CA
Canada
Prior art keywords
deoxythymidine
azido
treatment
prophylaxis
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000616284A
Other languages
English (en)
Inventor
David Walter Barry
Sandra Nusinoff Lehrman
Phillip Allen Furman
Martha Heider St Clair
Janet Litster Rideout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506869A external-priority patent/GB8506869D0/en
Priority claimed from GB858511774A external-priority patent/GB8511774D0/en
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523881A external-priority patent/GB8523881D0/en
Priority claimed from GB868603450A external-priority patent/GB8603450D0/en
Priority claimed from CA000556981A external-priority patent/CA1303032C/fr
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to CA000616284A priority Critical patent/CA1340519C/fr
Application granted granted Critical
Publication of CA1340519C publication Critical patent/CA1340519C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000616284A 1985-03-16 1992-01-13 Nucleosides antiviraux Expired - Fee Related CA1340519C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000616284A CA1340519C (fr) 1985-03-16 1992-01-13 Nucleosides antiviraux

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB8506869 1985-03-16
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
GB858511774A GB8511774D0 (en) 1985-05-09 1985-05-09 Antiviral compounds
GB8511774 1985-05-09
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
GB776899 1985-09-17
GB858523881A GB8523881D0 (en) 1985-09-27 1985-09-27 Antiviral compounds
GB8523881 1985-09-27
GB868603450A GB8603450D0 (en) 1986-02-12 1986-02-12 Antiviral compounds
GB8603450 1986-02-12
CA000556981A CA1303032C (fr) 1985-03-16 1988-01-20 Nucleosides antiviraux
CA000616284A CA1340519C (fr) 1985-03-16 1992-01-13 Nucleosides antiviraux

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000556981A Division CA1303032C (fr) 1985-03-16 1988-01-20 Nucleosides antiviraux

Publications (1)

Publication Number Publication Date
CA1340519C true CA1340519C (fr) 1999-04-27

Family

ID=33425751

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000616284A Expired - Fee Related CA1340519C (fr) 1985-03-16 1992-01-13 Nucleosides antiviraux

Country Status (1)

Country Link
CA (1) CA1340519C (fr)

Similar Documents

Publication Publication Date Title
EP0291633B1 (fr) Utilisation de la 3'azido-3'-déoxythymidine pour le traitement ou la prophylaxie des infections humaines à rétrovirus
AU622950B2 (en) Therapeutic nucleosides
US5071983A (en) Therapeutic nucleosides
EP0317128B1 (fr) Pyrimidine Nucléosides Anti-HIV
US5254539A (en) Method of treating HIV with 2',3'-dideoxyinosine
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
EP0306597B1 (fr) Nucléosides antiviraux
EP0594223B1 (fr) Combination de nucléosides thérapeutiques et d'autre agents thérapeutiques.
CA1340519C (fr) Nucleosides antiviraux
JPS61257925A (ja) 抗ウイルスヌクレオシド
CA1303032C (fr) Nucleosides antiviraux
IE56505B1 (en) Antiviral nucleosides
IL85096A (en) Use of (3-azido- (3-deoxythymidine) in the treatment or prevention of infections caused by human viruses
WO1988009332A1 (fr) Nucleosides a usage therapeutique
CA1327005C (fr) Nucleosides therapeutiques
CA1336821C (fr) Nucleosides pour usage therapeutique
EP0294113A1 (fr) Nucléosides thérapeutiques
AU644412B2 (en) 6-halo- and 2-amino-6-halo-purine 2',3'-dideoxy nucleosides and their use as antiviral agents
NZ224007A (en) 3'-azido-3'-deoxythymidine derivatives as antiviral agents
HU197209B (en) Process for producing pharmaceutical compositions containing 3'-azido-3'-deoxytimidine of antiviral activity againt human retrovirus
EP0544668A1 (fr) -6-fluoro-9-(2,3-didesoxy-b-d-glycero-pentofuranosyl)-9h-purines ainsi que leur emploi en tant qu'agents antiviraux

Legal Events

Date Code Title Description
MKLA Lapsed